Emerald Bioventures, LLC

1 filings 1 distinct issuers Active 2026-04-27 → 2026-04-27

1 STRATEGIC

Track Record

Total filings

1 SCHEDULE 13D

Distinct issuers

100% issuer diversity

Median stake

26.5%

40,216,160 avg shares

AI briefs cached

1/1

intent-classified filings

Filed	Form	Issuer	Stake	Shares	Intent
2026-04-27	SCHEDULE 13D	Galera Therapeutics, Inc.GRTX	26.50%	40,216,160	STRATEGIC	view →

Free. We email you when criteria match. One-click unsubscribe in every email.

Custom alerts on filer activity · full feed access · daily intelligence · API. $1,500/mo. Pilots welcome.